Skip to main content
Tech.euFundingExplorerBeta
Funding rounds/GenSight Biologics

GenSight Biologics

Series A
Paris, FranceFounded 2011Apr 2013
Healthtech

GenSight Biologics raised €32M in a Series A round in Apr 2013. The company is based in Paris, France. Investors in the round: Abingworth LLP, Index Ventures, Novartis Venture Fund. Data as of Nov 2026.

← GenSight Biologics
Amount raised
€32M
€32,000,000
Native amount
32,000,000 EUR
Stage
Series A
series a
Investors
3

Provenance & confidence

Unverified
Amount

Reported in EUR — no conversion. €32M

High confidence
Source

No source on record — unverified.

Unverified

Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.

Investors in this round

3 named
Abingworth LLPIndex VenturesNovartis Venture Fund
Date
Apr 2013
Round type
series a
Amount (EUR)
€32M

Other rounds

same company